520
Participants
Start Date
December 27, 2024
Primary Completion Date
December 23, 2030
Study Completion Date
April 6, 2032
Belantamab mafodotin
Belantamab mafodotin will be administered.
Lenalidomide
Lenalidomide will be administered.
Dexamethasone
Dexamethasone will be administered.
Daratumumab
Daratumumab will be administered.
RECRUITING
GSK Investigational Site, Kaohsiung City
RECRUITING
GSK Investigational Site, Brussels
RECRUITING
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
RECRUITING
GSK Investigational Site, Gosford NSW
RECRUITING
GSK Investigational Site, Box Hill
RECRUITING
GSK Investigational Site, Hornu
RECRUITING
GSK Investigational Site, Bruges
RECRUITING
GSK Investigational Site, Roeselare
RECRUITING
GSK Investigational Site, Ghent
RECRUITING
GSK Investigational Site, Taipei
RECRUITING
GSK Investigational Site, Pátrai
RECRUITING
GSK Investigational Site, Madrid
RECRUITING
GSK Investigational Site, Madrid
RECRUITING
GSK Investigational Site, Málaga
RECRUITING
GSK Investigational Site, Murcia
RECRUITING
GSK Investigational Site, Gijón
RECRUITING
GSK Investigational Site, Mobile
RECRUITING
GSK Investigational Site, Santander
RECRUITING
GSK Investigational Site, Ulsan
RECRUITING
GSK Investigational Site, Nantes
RECRUITING
GSK Investigational Site, Valladolid
RECRUITING
GSK Investigational Site, Meldola FC
RECRUITING
GSK Investigational Site, Thessaloniki
RECRUITING
GSK Investigational Site, Kingwood
RECRUITING
GSK Investigational Site, Bobigny
RECRUITING
GSK Investigational Site, Villejuif
RECRUITING
GSK Investigational Site, Beijing
RECRUITING
GSK Investigational Site, Shanghia
RECRUITING
GSK Investigational Site, Nanjing
RECRUITING
GSK Investigational Site, Tianjin
RECRUITING
GSK Investigational Site, Wenzhou
RECRUITING
GSK Investigational Site, Nanchang
RECRUITING
GSK Investigational Site, Guangzhou
RECRUITING
GSK Investigational Site, Shenzhen
RECRUITING
GSK Investigational Site, Capital Federal
RECRUITING
GSK Investigational Site, Córdoba
RECRUITING
GSK Investigational Site, Fitzroy
RECRUITING
GSK Investigational Site, Nanchang
RECRUITING
GSK Investigational Site, Athens
RECRUITING
GSK Investigational Site, Waterford
RECRUITING
GSK Investigational Site, Ancona
RECRUITING
GSK Investigational Site, Lublin
RECRUITING
GSK Investigational Site, Badalona
RECRUITING
GSK Investigational Site, Madrid
RECRUITING
GSK Investigational Site, Salamanca
RECRUITING
GSK Investigational Site, Rosario
RECRUITING
GSK Investigational Site, Viedma
RECRUITING
GSK Investigational Site, Ostrava
RECRUITING
GSK Investigational Site, Dresden
RECRUITING
GSK Investigational Site, Alexandroupoli
RECRUITING
GSK Investigational Site, Athens
RECRUITING
GSK Investigational Site, Athens
RECRUITING
GSK Investigational Site, Dublin
RECRUITING
GSK Investigational Site, Roma
RECRUITING
GSK Investigational Site, Aichi
RECRUITING
GSK Investigational Site, Ehime
RECRUITING
GSK Investigational Site, Ehime
RECRUITING
GSK Investigational Site, Fukuoka
RECRUITING
GSK Investigational Site, Fukushima
RECRUITING
GSK Investigational Site, Gunma
RECRUITING
GSK Investigational Site, Hyōgo
RECRUITING
GSK Investigational Site, Hyōgo
RECRUITING
GSK Investigational Site, Ibaraki
RECRUITING
GSK Investigational Site, Ishikawa
RECRUITING
GSK Investigational Site, Kanagawa
RECRUITING
GSK Investigational Site, Miyagi
RECRUITING
GSK Investigational Site, Nara
RECRUITING
GSK Investigational Site, Numakunai
RECRUITING
GSK Investigational Site, Sapporo
RECRUITING
GSK Investigational Site, Suita
RECRUITING
GSK Investigational Site, Tokyo
RECRUITING
GSK Investigational Site, Yamagata
RECRUITING
GSK Investigational Site, Hwasun
RECRUITING
GSK Investigational Site, Jeonju
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Seoul
RECRUITING
GSK Investigational Site, Barcelona
RECRUITING
GSK Investigational Site, Plymouth
Lead Sponsor
GlaxoSmithKline
INDUSTRY